Volume 29, Issue 4 pp. 228-232
Therapeutic Hotline

Pemphigus vulgaris-associated interstitial lung disease

Yi-Xiu Bai

Yi-Xiu Bai

Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China

Search for more papers by this author
Jin-Gang Chu

Jin-Gang Chu

Department of Radiology, No. 1 Hospital of China Medical University, Shenyang, China

Search for more papers by this author
Ting Xiao

Corresponding Author

Ting Xiao

Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China

Address correspondence and reprint requests to: Ting Xiao, MD, PhD, Professor, Vice chairman, Department of Dermatology, No. 1 Hospital of China Medical University, 155 North Nanjing Street, Shenyang 110001, China, or email: [email protected].Search for more papers by this author
Hong-Duo Chen

Hong-Duo Chen

Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China

Search for more papers by this author
First published: 11 March 2016
Citations: 5

ABSTRACT

Autoimmune bullous diseases (AIBDs)-associated interstitial lung disease (ILD) is extremely rare. Pemphigus vulgaris (PV) is an intraepidermal autoimmune blistering disease caused by circulating autoantibodies against desmoglein. To date, PV-associated ILD has rarely been reported in English literature. We report a rare association of PV and ILD. A 53-year-old Chinese female with PV for 8 months developed ILD after a relapse of PV for 2 months due to discontinuation of oral prednisone by herself. She was successfully treated by systemic methylprednisolone. Taken previously reported bullous pemphigoid-associated ILD and linear IgA/IgG bullous dermatosis-associated ILD together, in general, AIBDs-associated ILD occurs when AIBDs relapse or are not controlled, responds well to systemic corticosteroids, and has a relatively better prognosis when compared with rheumatoid arthritis- or dermatomyositis-associated ILD.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.